Topics
November/December 2016 | Special Focus: The Year In Review
Recapping the Past 12 Months
the staff of Retina Today
November/December 2015 | Special Focus: The Year In Review
In the Rearview: Highlights of Happenings From 2015
A brief look at significant events, innovative products, and other notable headlines from the past year.
From the staff of Retina Today
October 22, 2026
FDA Clears Opus Genetics' IND Application for OPGx-RDH12 Gene Therapy in Leber Congenital Amaurosis
October 21, 2026
Nanoscope Therapeutics Reports Sustained Visual Responses with OCT-Guided Nonviral Gene Delivery in Preclinical Study
Alcon Acquires Neurotech Pharmaceuticals for $550 Million, Adding Encelto to Retina Portfolio
October 20, 2026
EyePoint to Shift Focus, Cut Workforce Following Phase 3 Duravyu Results
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
